BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18500674)

  • 1. (-)-Epigallocatechin gallate inhibits basic fibroblast growth factor-stimulated interleukin-6 synthesis in osteoblasts.
    Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Yamauchi J; Harada A; Hosoi T; Ohta T; Kozawa O
    Horm Metab Res; 2008 Oct; 40(10):674-8. PubMed ID: 18500674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation.
    Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Hosoi T; Harada A; Ohta T; Kozawa O
    FEBS Lett; 2007 Apr; 581(7):1311-6. PubMed ID: 17350626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-Epigallocatechin gallate amplifies interleukin-1-stimulated interleukin-6 synthesis in osteoblast-like MC3T3-E1 cells.
    Kuroyanagi G; Otsuka T; Kondo A; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
    Biochimie; 2013 Oct; 95(10):1933-8. PubMed ID: 23851196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK.
    Takai S; Matsushima-Nishiwaki R; Adachi S; Natsume H; Minamitani C; Mizutani J; Otsuka T; Tokuda H; Kozawa O
    Mediators Inflamm; 2008; 2008():291808. PubMed ID: 19148296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation by p70 S6 kinase of FGF-2-stimulated VEGF release through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
    Takai S; Tokuda H; Hanai Y; Harada A; Yasuda E; Matsushima-Nishiwaki R; Kato H; Ogura S; Ohta T; Kozawa O
    J Bone Miner Res; 2007 Mar; 22(3):337-46. PubMed ID: 17181399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
    Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
    J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-kinase regulates thrombin-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
    Kato K; Otsuka T; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
    Int J Mol Med; 2011 Oct; 28(4):653-8. PubMed ID: 21750859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function of Rho-kinase in prostaglandin D2-induced interleukin-6 synthesis in osteoblasts.
    Tokuda H; Takai S; Matsushima-Nishiwaki R; Hanai Y; Adachi S; Minamitani C; Mizutani J; Otsuka T; Kozawa O
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):41-6. PubMed ID: 18771907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts.
    Yamauchi J; Takai S; Matsushima-Nishiwaki R; Hanai Y; Doi T; Kato H; Ogura S; Kato K; Tokuda H; Kozawa O
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):173-9. PubMed ID: 17949962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase.
    Tokuda H; Kozawa O; Uematsu T
    J Bone Miner Res; 2000 Dec; 15(12):2371-9. PubMed ID: 11127202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
    Hayashi K; Takai S; Matsushima-Nishiwaki R; Hanai Y; Kato K; Tokuda H; Kozawa O
    Life Sci; 2008 May; 82(19-20):1012-7. PubMed ID: 18407296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of SAPK/JNK in basic fibroblast growth factor-induced vascular endothelial growth factor release in osteoblasts.
    Tokuda H; Hirade K; Wang X; Oiso Y; Kozawa O
    J Endocrinol; 2003 Apr; 177(1):101-7. PubMed ID: 12697041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Epigallocatechin gallate inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
    Kato K; Otsuka T; Adachi S; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
    Mol Med Rep; 2011; 4(2):297-300. PubMed ID: 21468567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation by resveratrol of basic fibroblast growth factor-stimulated osteoprotegerin synthesis through suppression of Akt in osteoblasts.
    Kuroyanagi G; Otsuka T; Yamamoto N; Matsushima-Nishiwaki R; Nakakami A; Mizutani J; Kozawa O; Tokuda H
    Int J Mol Sci; 2014 Oct; 15(10):17886-900. PubMed ID: 25290095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho-kinase limits FGF-2-stimulated VEGF release in osteoblasts.
    Natsume H; Tokuda H; Adachi S; Takai S; Matsushima-Nishiwaki R; Kato K; Minamitani C; Niida S; Mizutani J; Kozawa O; Otsuka T
    Bone; 2010 Apr; 46(4):1068-74. PubMed ID: 20114091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMP-activated protein kinase inhibitor decreases prostaglandin F2α-stimulated interleukin-6 synthesis through p38 MAP kinase in osteoblasts.
    Kondo A; Otsuka T; Kato K; Natsume H; Kuroyanagi G; Mizutani J; Ito Y; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Int J Mol Med; 2012 Dec; 30(6):1487-92. PubMed ID: 23064268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation by platelet-derived growth factor-BB of FGF-2-stimulated VEGF release in osteoblasts.
    Tokuda H; Takai S; Hanai Y; Harada A; Matsushima-Nishiwaki R; Kato H; Ogura S; Kozawa O
    J Bone Miner Metab; 2008; 26(4):335-41. PubMed ID: 18600399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein (MAP) kinases are involved in interleukin-1 (IL-1)-induced IL-6 synthesis in osteoblasts: modulation not of p38 MAP kinase, but of p42/p44 MAP kinase by IL-1-activated protein kinase C.
    Miwa M; Kozawa O; Tokuda H; Uematsu T
    Endocrinology; 1999 Nov; 140(11):5120-5. PubMed ID: 10537140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E
    Kuroyanagi G; Tokuda H; Yamamoto N; Kainuma S; Fujita K; Ohguchi R; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Harada A; Kozawa O; Otsuka T
    Prostaglandins Other Lipid Mediat; 2017 Jan; 128-129():27-33. PubMed ID: 28163121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Rho-kinase in prostaglandin F2alpha-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
    Minamitani C; Otsuka T; Takai S; Matsushima-Nishiwaki R; Adachi S; Hanai Y; Mizutani J; Tokuda H; Kozawa O
    Mol Cell Endocrinol; 2008 Sep; 291(1-2):27-32. PubMed ID: 18586382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.